Sino Biopharmaceutical Limited (HKG:1177)
Hong Kong · Delayed Price · Currency is HKD 5.48
-0.13 (-2.32%)
Sep 10, 2026, 4:08 PM HKT
Sino Biopharmaceutical Market Cap
Sino Biopharmaceutical has a market cap or net worth of 97.6 billion as of September 10, 2026. Its market cap has decreased by -38.68% in one year.
Market Cap
97.60B
Enterprise Value
101.37B
Revenue
38.91B
Ranking
n/a
PE Ratio
35.89
Stock Price
5.48
ChartMarket Cap Chart
Since September 29, 2000, Sino Biopharmaceutical's market cap has increased from 329.97M to 97.60B, an increase of 29,477.71%. That is a compound annual growth rate of 24.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 97.60B | -11.66% |
| Dec 31, 2025 | 110.48B | 89.64% |
| Dec 31, 2024 | 58.26B | -8.75% |
| Dec 29, 2023 | 63.85B | -24.41% |
| Dec 30, 2022 | 84.46B | -17.53% |
| Dec 31, 2021 | 102.41B | -27.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 313.38B |
| WuXi Biologics | 202.31B |
| Innovent Biologics | 174.44B |
| Sichuan Kelun-Biotech Biopharmaceutical | 114.97B |
| Akeso | 88.61B |
| Genscript Biotech | 75.84B |
| RemeGen | 66.99B |
| Biocytogen Pharmaceuticals (Beijing) | 56.24B |